Related Experiment Videos
Interaction between duodenase and alpha1-proteinase inhibitor
I P Gladysheva1, N A Popykina, T S Zamolodchikova
1Department of Chemical Enzymology, School of Chemistry, Lomonosov Moscow State University, Moscow, 119899, Russia. gladysheva@enzyme.chem.msu.ru
Biochemistry. Biokhimiia
|June 26, 2001
Summary
Human serum alpha1-proteinase inhibitor (alpha1-PI) effectively inhibits duodenase, a serine proteinase. This interaction, characterized by a suicide inhibition mechanism and a stable complex, suggests alpha1-PI acts as a duodenase inhibitor in vivo.
Area of Science:
- Biochemistry
- Enzymology
- Protease Inhibitor Research
Background:
- Duodenase is a recently identified serine proteinase.
- Alpha1-proteinase inhibitor (alpha1-PI) is a key protease inhibitor in human serum.
Purpose of the Study:
- To investigate the interaction between duodenase and alpha1-proteinase inhibitor (alpha1-PI).
- To elucidate the mechanism and kinetics of this enzyme-inhibitor interaction.
Main Methods:
- Stoichiometry determination.
- Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to detect enzyme-inhibitor complexes.
- Kinetic analysis to determine equilibrium and inhibition constants.
Main Results:
- The stoichiometry of inhibition was determined to be 1.2 mol/mol.
- A stable duodenase-alpha1-PI complex was confirmed using SDS-PAGE.
- The interaction followed a suicide inhibition mechanism.
- Equilibrium and inhibition constants were calculated as 13 ± 3 nM and (1.9 ± 0.3)×10^5 M⁻¹·sec⁻¹, respectively.
Conclusions:
- Alpha1-proteinase inhibitor (alpha1-PI) is proposed as a physiological inhibitor of duodenase in vivo.
- The findings are based on the association rate constant and the co-localization of both proteins.